genistein nanosuspension (BIO 300) / Humanetics  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
genistein nanosuspension (BIO 300) / Humanetics
NCT00504335: Safety and Pharmacokinetic Study of BIO 300 Capsules

Completed
1
24
US
BIO 300 Capsules
Humanetics Corporation, United States Department of Defense
Acute Radiation Syndrome
09/07
10/07
NCT04650555: BIO 300 Oral Powder Safety and Pharmacokinetics

Completed
1
34
US
BIO 300 Oral Powder, BIO 300, Genistein
Humanetics Corporation, United States Department of Defense, Joint Warfighter Medical Research Program
Acute Radiation Syndrome
07/21
07/21

Download Options